PURPOSE: To evaluate the lipopolysaccharide (LPS)-induced pro-inflammatory cytokine response by peripheral blood mononuclear cells (PBMCs) from XLA patients. METHODS: Thirteen patients with XLA were included in the study. LPS-induced TNF-α, IL-1β, IL-6, and IL-10 production was determined in PBMCs from patients and matched healthy controls by ELISA. Cytokine production was correlated with the severity of mutation, affected domain and clinical characteristics. RESULTS: In response to LPS, PBMCs from XLA patients produced significantly higher amounts of pro-inflammatory cytokines and IL-10 compared to controls, and this production was influenced neither by the severity of the mutation nor the affected domain. PBMCs from patients with a history of more hospital admissions before their diagnosis produced higher levels of TNF-α. PBMCs from patients with lower serum IgA levels showed a higher production of TNF-α and IL-1β. Less severe (punctual) mutations in the Btk gene were associated with higher serum IgG levels at diagnosis. CONCLUSIONS: Our results demonstrate a predominantly inflammatory response in XLA patients after LPS stimulation and suggest a deregulation of TLR signaling in the absence of Btk. This response may be influenced by environmental factors.
PURPOSE: To evaluate the lipopolysaccharide (LPS)-induced pro-inflammatory cytokine response by peripheral blood mononuclear cells (PBMCs) from XLA patients. METHODS: Thirteen patients with XLA were included in the study. LPS-induced TNF-α, IL-1β, IL-6, and IL-10 production was determined in PBMCs from patients and matched healthy controls by ELISA. Cytokine production was correlated with the severity of mutation, affected domain and clinical characteristics. RESULTS: In response to LPS, PBMCs from XLA patients produced significantly higher amounts of pro-inflammatory cytokines and IL-10 compared to controls, and this production was influenced neither by the severity of the mutation nor the affected domain. PBMCs from patients with a history of more hospital admissions before their diagnosis produced higher levels of TNF-α. PBMCs from patients with lower serum IgA levels showed a higher production of TNF-α and IL-1β. Less severe (punctual) mutations in the Btk gene were associated with higher serum IgG levels at diagnosis. CONCLUSIONS: Our results demonstrate a predominantly inflammatory response in XLA patients after LPS stimulation and suggest a deregulation of TLR signaling in the absence of Btk. This response may be influenced by environmental factors.
Authors: Caroline A Jefferies; Sarah Doyle; Cornelia Brunner; Aisling Dunne; Elizabeth Brint; Claudia Wietek; Eva Walch; Thomas Wirth; Luke A J O'Neill Journal: J Biol Chem Date: 2003-04-30 Impact factor: 5.157
Authors: Pearl Gray; Aisling Dunne; Constantinos Brikos; Caroline A Jefferies; Sarah L Doyle; Luke A J O'Neill Journal: J Biol Chem Date: 2006-01-26 Impact factor: 5.157
Authors: Maroof Hasan; Gabriela Lopez-Herrera; K Emelie M Blomberg; Jessica M Lindvall; Anna Berglöf; C I Edvard Smith; Leonardo Vargas Journal: Immunology Date: 2007-08-28 Impact factor: 7.397
Authors: Ashley Mansell; Rosealee Smith; Sarah L Doyle; Pearl Gray; Jennifer E Fenner; Peter J Crack; Sandra E Nicholson; Douglas J Hilton; Luke A J O'Neill; Paul J Hertzog Journal: Nat Immunol Date: 2006-01-15 Impact factor: 25.606
Authors: Christopher Paustian; Richard Caspell; Terrence Johnson; Peter A Cohen; Suyu Shu; Shuwen Xu; Brian J Czerniecki; Gary K Koski Journal: Hum Immunol Date: 2010-10-15 Impact factor: 2.850
Authors: Vivian P Hernandez-Trujillo; Chris Scalchunes; Charlotte Cunningham-Rundles; Hans D Ochs; Francisco A Bonilla; Ken Paris; Leman Yel; Kathleen E Sullivan Journal: J Clin Immunol Date: 2014-06-10 Impact factor: 8.317
Authors: Afitap Derya Köprülü; Renate Kastner; Sebastian Wienerroither; Caroline Lassnig; Eva Maria Putz; Olivia Majer; Benjamin Reutterer; Veronika Sexl; Karl Kuchler; Mathias Müller; Thomas Decker; Wilfried Ellmeier Journal: PLoS One Date: 2013-03-27 Impact factor: 3.240
Authors: Francisco Rivas-Larrauri; Lorena Aguilar-Zanela; Paola Castro-Oteo; Luis Adrian Rosales-Hernandez; Francisco Otero-Mendoza; Gabriela López-Herrera; Javier Ordoñez-Ortega; Martín Garrido-García; Marco Antonio Yamazaki-Nakashimada Journal: Rheumatol Int Date: 2019-07-16 Impact factor: 3.580